Follow the CARsgen Therapeutics Holdings Ltd. - B stock price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares trade on the HK market, under the authority of HKEX. Market capitalisation: €7.7bn. The latest transaction was reported on 4 August 2026 (Sale). Among the most active insiders: Guo Huaqing. All data is free.
9
Insider Decl.
n/a
Thresholds
n/a
3 ops.
Buy Volume
n/a
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CARsgen Therapeutics Holdings Ltd. - B Hold (neutral), based on 2 analysts. Average price target: HK$18.33.
Fundamental score
Ranked 23,232 of 29,062 companies
30.7
score / 100
Value
28
Quality
34
FCF yld-3.2%
Earn yld-1.3%
EV/EBITDA·
ROE-9.6%
Gross mgn64%
Net mgn-78%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
CARsgen Therapeutics Holdings Ltd. es una empresa biofarmacéutica centrada en el desarrollo de terapias celulares para el tratamiento del cáncer. Se especializa en tecnologías CAR-T para mejorar los resultados de los pacientes.